Gilla Kaplan
Director · 3 filings · Latest: Jun 2, 2026
Avalo Therapeutics, Inc.
Tyra Biosciences, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVTX | Gilla Kaplan | Director | Mar 28, 2026 | Option Exercise | — | 3,166 | — | 6,333 | |
TYRA | Gilla Kaplan | Director | Mar 26, 2026 | Option Exercise | $2.25 | 53,172 | $119.6K | 81,403 | |
TYRA | Gilla Kaplan | Director | Mar 25, 2026 | Sale | $36.97 | 14,295 | $528.5K | 28,231 | |
TYRA | Gilla Kaplan | Director | Mar 25, 2026 | Option Exercise | $2.25 | 14,295 | $32.2K | 42,526 | |
TYRA | GILLA KAPLAN | — | Mar 26, 2026 | Proposed Sale | $37.75 | 53,172 | $2.0M | — | |
TYRA | GILLA KAPLAN | — | Mar 25, 2026 | Proposed Sale | $36.97 | 14,295 | $528.5K | — | |
TYRA | GILLA KAPLAN | — | Jun 18, 2025 | Proposed Sale | $9.78 | 9,568 | $93.6K | — | |
TYRA | GILLA KAPLAN | — | Jun 17, 2025 | Proposed Sale | $10.35 | 10 | $104 | — | |
TYRA | GILLA KAPLAN | — | Jun 16, 2025 | Proposed Sale | $10.38 | 6,814 | $70.7K | — | |
TYRA | GILLA KAPLAN | — | Jun 13, 2025 | Proposed Sale | $10.31 | 15,000 | $154.6K | — | |
TYRA | GILLA KAPLAN | — | Jun 12, 2025 | Proposed Sale | $10.31 | 30,000 | $309.3K | — |